Monte Rosa Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:GLUE Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
24 Mar 25	BuyUS$58,383	Chandra Leo	Individual	10,000	US$5.84
29 Oct 24	SellUS$621,801	Versant Venture Management, LLC	Company	67,905	US$9.41
28 Oct 24	SellUS$869,240	Versant Venture Management, LLC	Company	89,990	US$9.66
20 Sep 24	SellUS$7,395,203	Versant Venture Management, LLC	Company	1,132,566	US$6.53
13 Sep 24	SellUS$3,404,791	Versant Venture Management, LLC	Company	567,213	US$6.16
05 Jul 24	SellUS$6,166	Edmund Dunn	Individual	1,610	US$3.83
03 Jun 24	SellUS$4,876	Edmund Dunn	Individual	1,207	US$4.04

Insider Trading Volume

Insider Buying: GLUE insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GLUE?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	451,521	0.708%
VC/PE Firms	13,345,220	20.9%
Hedge Funds	18,581,775	29.1%
Institutions	31,371,389	49.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 97.85% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.5%	New Enterprise Associates, Inc.	7,692,298	US$30.5m	0%	1.97%
10.8%	T. Rowe Price Group, Inc.	6,644,136	US$26.4m	-6.64%	no data
9.2%	BVF Partners L.P.	5,660,132	US$22.5m	105%	0.89%
9.19%	Versant Venture Management, LLC	5,652,922	US$22.4m	0%	10.88%
7.99%	Baker Bros. Advisors LP	4,916,095	US$19.5m	0%	0.16%
7.6%	FMR LLC	4,674,108	US$18.6m	-15.8%	no data
7.55%	Avoro Capital Advisors LLC	4,645,548	US$18.4m	6.92%	0.3%
6.12%	BlackRock, Inc.	3,766,708	US$15.0m	-1.91%	no data
5.46%	Suvretta Capital Management, LLC	3,360,000	US$13.3m	115%	0.56%
5.04%	The Vanguard Group, Inc.	3,100,036	US$12.3m	-1.78%	no data
2.39%	Aisling Capital Management LP	1,472,331	US$5.8m	0%	2.09%
2.38%	GV Management Company, LLC	1,464,015	US$5.8m	0%	0.59%
2.29%	HBM Partners Ltd.	1,407,040	US$5.6m	0%	0.64%
1.63%	Geode Capital Management, LLC	1,004,062	US$4.0m	-3.14%	no data
1.3%	State Street Global Advisors, Inc.	801,257	US$3.2m	-25.6%	no data
1.15%	Parkwood LLC, Asset Management Arm	708,000	US$2.8m	119%	0.26%
0.72%	Norges Bank Investment Management	445,868	US$1.8m	0%	no data
0.68%	Markus Warmuth	416,538	US$1.7m	0%	no data
0.61%	Northern Trust Global Investments	373,207	US$1.5m	-1%	no data
0.6%	Marshall Wace LLP	371,738	US$1.5m	-25.6%	no data
0.6%	Morgan Stanley, Investment Banking and Brokerage Investments	370,368	US$1.5m	-83.2%	no data
0.59%	Charles Schwab Investment Management, Inc.	361,535	US$1.4m	-2.41%	no data
0.54%	Millennium Management LLC	330,467	US$1.3m	613%	no data
0.47%	Readystate Asset Management LP	287,000	US$1.1m	0%	0.12%
0.43%	Dimensional Fund Advisors LP	262,990	US$1.0m	81.6%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/27 13:05
End of Day Share Price	2025/05/23 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Monte Rosa Therapeutics, Inc. is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Zhiqiang Shu	Berenberg
Richard J. Law	Credit Suisse
Michael Schmidt	Guggenheim Securities, LLC